I Just Had a Melanoma. What Are My Odds of Getting Another One?
Medically reviewed by Gunjan Modi, MD, FAAD, FACMS, board-certified dermatologist and fellowship-trained Mohs surgeon · Updated October 2, 2026
The short answer
A second melanoma is a new skin cancer, not the first one coming back and not the first one spreading. After a melanoma, your chance of another one is higher than average, about 9 times higher in large U.S. studies, but most people never get a second one. In the largest recent U.S. study of people treated for an invasive melanoma, about 4 in 100 had a new melanoma within 5 years and about 7 in 100 within 10 years. The extra risk is highest in the first year and stays above average for at least 20 years, which is why skin checks continue for life. Your own number depends on your age, your skin, your moles, and your family history.

A second melanoma is a new cancer, not the first one coming back
Three different things can happen after a melanoma, and they get mixed up. A recurrence means the original melanoma has come back at or near the scar. Spread, or metastasis, means cells from the original melanoma have traveled to lymph nodes or beyond. A second primary melanoma is a brand-new melanoma that starts on its own, usually somewhere else on the skin. This page is about the third one.
The distinction matters because the odds are separate. A thin melanoma that was fully removed has a low chance of coming back or spreading. The same person still has a raised chance of growing a new one, because the skin, the moles, and the sun history that produced the first melanoma are all still there. A new spot in or near the scar needs to be seen either way. The biopsy, not the location, decides what it is.
Two kinds of numbers: about 9 times, and about 4 in 100
You will hear two kinds of numbers, and both are true at once. The first is a relative risk. In a U.S. cancer registry study of 89,515 melanoma survivors, new melanomas occurred at about 9 times the rate expected in the general population. That sounds alarming until you remember that the general population's rate is low.
The second is an absolute risk, the share of people it actually happens to. In the largest recent U.S. study, 152,811 people treated for an invasive melanoma were followed through the national SEER registry. A second melanoma was found in 3.9 percent within 5 years and in 6.7 percent within 10 years. Put the other way, about 93 of every 100 had not had a second melanoma ten years on.
The longer a study runs, the higher the number climbs, because the risk does not stop. Older U.S. data put the 20-year figure at 5.3 percent. In the Netherlands it was 5 to 6 percent at 20 years. In Queensland, Australia, which has the highest melanoma rates in the world, 16.3 percent of survivors had a second invasive melanoma within 40 years. Specialist clinics that see people with many moles or strong family histories report higher numbers, around 8 to 11 percent at 5 years, and studies that also count melanoma in situ, the earliest form, run higher too. When you read a figure, ask which kind of number it is and who was counted.
Figure
Out of 100 people treated for an invasive melanoma
How many had a new, separate melanoma within 5 and within 10 years, in the largest recent U.S. registry study.
Within 5 years3.9%
Within 10 years6.7%
Filled: had a second melanomaOutline: had not
Wiener and colleagues, Annals of Surgical Oncology, 2022: 152,811 adults in the U.S. SEER registry treated for an invasive melanoma between 1998 and 2012, counting a second melanoma found three months or more after the first. Each square is one percentage point, rounded to the nearest whole square; the exact values are printed. These are averages across everyone in the study. Your own chance depends on your age, skin, moles, and family history, and people followed in specialist clinics for many moles or a family history have reported higher figures.
See the numbers as a table
| Time since first melanoma | Had a second melanoma | 95% confidence interval |
|---|---|---|
| 5 years | 3.9% | 3.8–4.0% |
| 10 years | 6.7% | 6.6–6.9% |
When: the first year is busiest, and the risk does not expire
The chance of a second melanoma is highest right after the first. In the U.S. registry study, the rate in months 2 through 12 after diagnosis was about 17 times the general population's. Part of that is real, and part is detection: the first full-skin examination after a melanoma diagnosis finds spots that were already there.
After the first year the risk settles but does not go away. In a large California health plan, about 2 percent of melanoma patients had a second melanoma in the first year, and then roughly 1 percent per year, year after year, through 15 years of follow-up. In the Netherlands, people who were still clear at 5 years had a further 4.6 percent chance over the next 5 years. And in the U.S. registry, people 20 or more years out were still developing melanoma at more than 5 times the average rate.
That is the most useful fact on this page. A quiet first year is good news. It is not a reason to stop looking.
Figure
How many times the average rate, and for how long
New melanomas among 89,515 U.S. melanoma survivors, compared with the rate expected in the general population.
General populationthe comparison rate
Months 2 to 12 after diagnosis
All years of follow-up combined
20 or more years after diagnosis
Bradford and colleagues, Archives of Dermatology, 2010, U.S. SEER registry, 1973 to 2006. The bars show how many times more often a new melanoma occurred than would be expected in people of the same age and sex without a melanoma history. The first year is the busiest, partly because the first full-skin examination after a diagnosis finds spots that were already there. Twenty or more years later the rate was still more than five times the average. A multiple of the average rate is not a percentage: the average rate itself is low, and the share of people who actually get a second melanoma is shown in the first figure.
See the numbers as a table
| Period | Times the expected rate | 95% confidence interval |
|---|---|---|
| Months 2 to 12 after diagnosis | 16.94 | not reported in the paper's text |
| All follow-up combined | 8.61 | men 8.04–8.78; women 8.47–9.54 |
| 20 or more years after diagnosis | 5.58 | 4.80–6.44 |
What raises your personal risk
A 2024 analysis pooled 27 studies covering 413,181 people with melanoma to see who is most likely to get another. The strongest factor was an inherited change in the CDKN2A gene, found in a small number of melanoma-prone families, which raised the odds about fivefold. Having one or more atypical moles tripled the odds. Having many moles of any kind raised them about 2.6-fold, and a family history of melanoma about 1.8-fold. Men, people with fair skin, and older people also had higher rates: about 46 percent higher for men, 44 percent higher for light skin, and 19 percent higher for every additional 10 years of age.
Sun and tanning matter too. In one U.S. series, people who had used indoor tanning beds had nearly three times the odds of multiple melanomas. An Australian study concluded that people who have had a melanoma can expect to reduce their risk of another by cutting back on recreational sun exposure, whatever their age.
One thing that does not lower your risk is having had a thin melanoma. Studies disagree about whether a thicker first melanoma raises or lowers the chance of a recorded second one, but none of them puts people with thin or in situ melanomas in a low-risk group.
Figure
What raises the chance of another melanoma
Pooled results from 27 studies of 413,181 people with melanoma.
Inherited CDKN2A gene change
Odds ratio
One or more atypical moles
Odds ratio
Many moles
Odds ratio
Family history of melanoma
Odds ratio
Male sex
Hazard ratio
Light skin
Hazard ratio
Each additional 10 years of age
Hazard ratio
Smith, Cust, and Lo, British Journal of Dermatology, 2024. Each point shows how much a factor multiplied the chance of a subsequent melanoma compared with people without that factor; the line shows the 95% confidence interval. Odds ratios and hazard ratios are two ways of expressing a multiplier and are labeled as the paper reports them. They are not percentages, and they are not simply added together. Inadequate sun protection also trended toward higher risk in this analysis but did not reach statistical significance and is not shown.
See the numbers as a table
| Factor | Measure | Estimate | 95% confidence interval |
|---|---|---|---|
| Inherited CDKN2A gene change | Odds ratio | 5.29 | 2.70–10.37 |
| One or more atypical moles | Odds ratio | 3.01 | 1.52–5.97 |
| Many moles | Odds ratio | 2.63 | 1.61–4.30 |
| Family history of melanoma | Odds ratio | 1.79 | 1.25–2.56 |
| Male sex | Hazard ratio | 1.46 | 1.40–1.53 |
| Light skin | Hazard ratio | 1.44 | 1.23–1.70 |
| Each additional 10 years of age | Hazard ratio | 1.19 | 1.14–1.24 |
My first melanoma was in situ. Does that change anything?
Melanoma in situ is melanoma confined to the top layer of the skin. Removing it cures it, and it does not spread. But it carries the same message about your skin. In a Dutch registry, the 20-year chance of a later invasive melanoma was 6.2 percent after an in situ first melanoma and 5.0 percent after an invasive one. In the U.S. registry, the rate of a new invasive melanoma after an in situ melanoma was 8 to 12 times the general population's, close to the figure after an invasive melanoma. An in situ melanoma still means lifelong skin exams.
Where on the body
Across studies, about a third to a half of second melanomas appear in the same general body region as the first, more often than chance would predict. Most appear somewhere else. That is why a proper follow-up exam covers the whole skin, including the scalp, the back, the buttocks, and the soles of the feet, and not just the scar.
Will a second melanoma be worse than the first?
Usually it is found earlier. In a Dutch registry of 2,284 people with more than one melanoma, the median thickness fell from 0.90 millimeters for the first melanoma to 0.65 millimeters for the second, because someone was looking. Thinner melanomas are more often cured by surgery alone.
But not always. In the same registry, the second melanoma was a higher stage than the first in 16.2 percent of people, the same stage in 48.7 percent, and a lower stage in 35.1 percent. Each invasive melanoma carries its own risk and needs its own staging and treatment. Several large population studies that corrected for the statistical quirks of counting survivors found that people with two or more invasive melanomas had, on average, a somewhat worse long-term outlook than people with one; one large study found no significant difference. An additional in situ melanoma did not change melanoma survival in one large analysis. Finding the next melanoma early is what follow-up is for.
Figure
Is the second melanoma worse than the first?
Stage of the second melanoma compared with the first, among 2,284 people with more than one melanoma in a Dutch national registry.
El Sharouni and colleagues, JAMA Dermatology, 2019. Stage here is the tumor category based on thickness and ulceration. In the same registry the median thickness fell from 0.90 millimeters for the first melanoma to 0.65 millimeters for the second, which is what follow-up is meant to do. The dark segment is the reason follow-up never relaxes: about one in six second melanomas was further along than the first.
See the numbers as a table
| Measure | Value |
|---|---|
| Second melanoma a higher T category than the first | 16.2% |
| Same T category | 48.7% |
| Lower T category | 35.1% |
| Median thickness, first melanoma | 0.90 mm |
| Median thickness, second melanoma | 0.65 mm |
Other skin cancers, and other cancers
Melanoma survivors also get more of the common skin cancers. Pooled studies put basal cell carcinoma at about 5 times the general rate and squamous cell carcinoma at about 2.6 times; roughly 4 percent and 2.5 percent of melanoma survivors developed one during follow-up. The same sun that caused the melanoma caused these, and the same skin exam finds them.
Cancers inside the body show small increases in registry data, on the order of 10 to 30 percent for breast, prostate, and non-Hodgkin lymphoma, with a larger relative increase for thyroid cancer in one U.S. analysis. Some of that is shared risk and some is simply being examined more often. In Australian data, the 5-year chance of another melanoma, counting in situ, was 7.6 percent, higher than the chance of prostate cancer in men or breast cancer in women, each 2.8 percent, or colon cancer at 0.6 percent. Keep your usual age-appropriate cancer screening. A genetics visit is reserved for selected families.
Your follow-up plan
National guidelines agree on the substance, even if the calendars differ. The National Comprehensive Cancer Network calls for at least an annual skin examination for life. For stage 0 through IIA melanoma it recommends a history and physical examination, with attention to the skin and lymph nodes, every 6 to 12 months for 5 years and then yearly. For stage IIB and higher it recommends every 3 to 6 months for 2 years, then every 3 to 12 months for 3 years, then yearly. The American Academy of Dermatology and the European guidelines say the same in substance, and all of them admit that the exact intervals rest on limited evidence. Your surgeon sets your schedule from your stage, your moles, and your family history.
- A full-skin examination by a dermatologist on the schedule you were given, for life. It looks for a new melanoma and for the common skin cancers that follow the same sun.
- A self-check about once a month, which is the NCCN patient guide's advice. Use a mirror or a partner for your back and scalp, and call sooner for any new or changing spot.
- Total-body photography and digital dermoscopy for people with many moles or more than one melanoma. In specialist programs for very-high-risk patients examined every 6 months with these tools, most new melanomas were found in situ or under 1 millimeter thick. No trial has proved that any schedule or tool saves lives; they find melanomas early, which is the point. Ask us whether this fits your situation.
- Sun protection and no tanning beds, at any age.
- Genetic counseling if you have had 3 or more invasive melanomas, including one before age 45, or if 3 or more relatives on one side of your family have had melanoma or pancreatic cancer.
- Routine scans are not how a new skin melanoma is found. Scans look for spread and are used only when your stage calls for them.
What the numbers cannot tell you
Every study on this page defined a second melanoma a little differently, counted in situ lesions differently, and followed a different population, from a national registry to a clinic that sees only the highest-risk patients. Surveillance itself finds more. No study can give you a personal percentage. What the research gives you is a range, a list of what raises and lowers it, and a clear plan. That is enough to act on.
This page is general education, not medical advice for your specific situation. Published study results are averages across many people and are not a prediction of your outcome; your follow-up plan depends on your stage, your skin, and your history. If you have had a melanoma and want a plain answer about your own follow-up, call us at (972) 378-0620.
Common questions
Answers reflect the general case — a physician who can see the wound always beats a page that cannot.
Selected peer-reviewed literature
The data behind the answer.
- Wiener AA, et al. Incidence of second primary melanoma in cutaneous melanoma survivors. Annals of Surgical Oncology. 2022;29(9):5925–5932.
- Bradford PT, et al. Increased risk of second primary cancers after a diagnosis of melanoma. Archives of Dermatology. 2010;146(3):265–272.
- Goggins WB, Tsao H. A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer. 2003;97(3):639–643.
- van der Leest RJ, et al. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989–2008. British Journal of Dermatology. 2012;167(6):1321–1330.
- Youlden DR, et al. Second primary invasive cutaneous melanomas in Queensland over 4 decades. Journal of Investigative Dermatology. 2026;146(8):2223–2231.
- Ni Y, et al. Absolute risk of developing a second primary cancer after a first primary melanoma: an Australian population-based cohort study. American Journal of Epidemiology. 2026;195(2):346–357.
- Ferrone CR, et al. Clinicopathological features of and risk factors for multiple primary melanomas. JAMA. 2005;294(13):1647–1654.
- Lallas A, et al. Second primary melanomas in a cohort of 977 melanoma patients within the first 5 years of monitoring. Journal of the American Academy of Dermatology. 2020;82(2):398–406.
- Moore MM, et al. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011. Journal of the American Academy of Dermatology. 2015;73(4):630–636.
- Schuurman MS, et al. Risk factors for second primary melanoma among Dutch patients with melanoma. British Journal of Dermatology. 2017;176(4):971–978.
- Smith J, Cust AE, Lo SN. Risk factors for subsequent primary melanoma in patients with previous melanoma: a systematic review and meta-analysis. British Journal of Dermatology. 2024;190(2):174–183.
- Karapetyan L, et al. Indoor tanning exposure in association with multiple primary melanoma. Cancer. 2021;127(4):560–568.
- Kricker A, et al. Ambient UV, personal sun exposure and risk of multiple primary melanomas. Cancer Causes & Control. 2007;18(3):295–304.
- Balamurugan A, et al. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin. Journal of the American Academy of Dermatology. 2011;65(5 Suppl 1):S69–S77.
- Helgadottir H, et al. Multiple primary melanoma incidence trends over five decades: a nationwide population-based study. Journal of the National Cancer Institute. 2021;113(3):318–328.
- Sarver MM, et al. Survival and tumor characteristics of patients presenting with single primary versus second primary melanoma lesions. Journal of the American Academy of Dermatology. 2023;88(5):1033–1039.
- El Sharouni MA, et al. Comparison of survival between patients with single vs multiple primary cutaneous melanomas. JAMA Dermatology. 2019;155(9):1049–1056.
- Youlden DR, et al. Ten-year survival after multiple invasive melanomas is worse than after a single melanoma: a population-based study. Journal of Investigative Dermatology. 2016;136(11):2270–2276.
- Peek G, et al. Survival in patients with multiple primary melanomas: systematic review and meta-analysis. Journal of the American Academy of Dermatology. 2020;83(5):1406–1414.
- Kricker A, et al. Survival for patients with single and multiple primary melanomas: the Genes, Environment, and Melanoma study. JAMA Dermatology. 2013;149(8):921–927.
- Youlden DR, et al. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: a registry-based follow-up study. Australasian Journal of Dermatology. 2016;57(1):57–60.
- Sun H, et al. Melanoma survivors are at increased risk for second primary keratinocyte carcinoma. International Journal of Dermatology. 2022;61(11):1397–1404.
- Spanogle JP, et al. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study. Journal of the American Academy of Dermatology. 2010;62(5):757–767.
- Guitera P, et al. Efficiency of detecting new primary melanoma among individuals treated in a high-risk clinic for skin surveillance. JAMA Dermatology. 2021;157(5):521–530.
- Moloney FJ, et al. Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study. JAMA Dermatology. 2014;150(8):819–827.
- Swetter SM, et al. Guidelines of care for the management of primary cutaneous melanoma. Journal of the American Academy of Dermatology. 2019;80(1):208–250.
- National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Melanoma: Cutaneous; and NCCN Guidelines for Patients: Melanoma, 2026.
- Amaral T, et al. Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up. Annals of Oncology. 2025;36(1):10–30.
If you have had a melanoma
Follow-up skin examinations and the removal of whatever they find are the daily work of this practice. We treat melanoma and the other common skin cancers, and we will set a schedule that fits your history.
Mohs Surgery for Melanoma
The most serious common skin cancer — treated here with same-day, margin-controlled Mohs surgery for appropriate cases.
Basal Cell Carcinoma
The most common skin cancer — slow to spread, but destructive locally. Mohs offers the most precise removal.
Squamous Cell Carcinoma
The second most common skin cancer — treated promptly because it can spread. High-risk tumors get immunostained margin control.
Request a Consultation
A question about a spot that worries you?
Call us, or send an appointment request — requests receive a call back within one business day.
(972) 378-06206100 Windhaven Parkway, Plano, TX 75093 · Mon-Thurs: 7:30-4 | Fri: 10-2